| U.N. Passes Polio Plan; Faces Shortfall The World Health Organization approved a three-year plan to eradicate polio, bringing a two-decade battle to a critical juncture as funding falls short and the disease is on a surprise upturn. online.wsj.com |
Baxter's Profit Drops 8.9% Baxter International's second-quarter earnings fell 8.9%, including a charge, as it faced macroeconomic headwinds and individual product issues. online.wsj.com |
Merck: All Kids' Vaccines Now Available Merck said that for the first time since 2007, its entire lineup of pediatric vaccines is now available—a milestone in the company's efforts to recover from a series of vaccine manufacturing and supply setbacks. online.wsj.com |
Why Next-Gen Biofuels Look Attractive for Biotech Investors The Burrill Report submits: By John Hamer It’s interesting that biotech publications focused on healthcare have reported the news of the Amyris (AMRS) IPO, a next-generation biofuel company. Biotech investors will probably look seriously at this area. Much of the underlying technology, such as genomics and synthetic biology, is shared with traditional biotechs. The first two companies out of the chute, Amyris and Codexis (CDXS), also have healthcare-related projects. What do next-generation biofuel companies offer the biotech investor? Complete Story » seekingalpha.com |
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Clarient, Inc. in Connection with the Proposed Acquisition of the Company by GE Healthcare [Business Wire] - Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Clarient, Inc. related to the Company’s agreement to be acquired by GE Healthcare, a unit of General Electric Company . us.rd.yahoo.com |